Farr Miller & Washington’s Halozyme HALO Stock Holding History

Farr Miller & Washington’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,500	Closed	-$313K	–	189
2021 Q1	$313K	Hold	7,500	–	–	0.02%	150
2020 Q4	$320K	Buy	+7,500	New	+$270K	0.02%	142
2020 Q3	–	Sell	-7,500	Closed	-$201K	–	172
2020 Q2	$201K	Buy	+7,500	New	+$169K	0.02%	152
2018 Q4	–	Sell	-43,417	Closed	-$789K	–	137
2018 Q3	$789K	Hold	43,417	–	–	0.07%	74
2018 Q2	$732K	Hold	43,417	–	–	0.07%	71
2018 Q1	$851K	Buy	+43,417	New	+$841K	0.08%	73

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Farr Miller & Washington's HALO Position: Q2 2021 in Review

Farr Miller & Washington sold out of Halozyme (HALO) in Q2 2021, closing a stake of 7,500 shares — an estimated $313K sold.

Farr Miller & Washington first reported a position in HALO in Q1 2018 and held it in 6 quarters. The position peaked at $851K in Q1 2018. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

Farr Miller & Washington reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
Farr Miller & Washington sold 7,500 Halozyme shares in Q2 2021, an estimated $313K.
Farr Miller & Washington first reported a position in Halozyme in Q1 2018 and held it in 6 quarters.
Farr Miller & Washington's Halozyme position peaked at $851K in Q1 2018.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Farr Miller & Washington's 13F filing for Q2 2021, filed 16 Aug 2021.